Delivery Order SPE2DB22D3401-SPE2DB25FT2FS

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,107.86, is for the delivery of Cimzia 2x200 mg/ml syringe kits. This is a firm fixed-price delivery order contract with an ultimate completion date of November 15, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,303.44, is for the delivery of CIMZIA 2X200 MG/ML syringe kits. This is a firm-fixed-price delivery order contract that runs through January 15, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,506.34, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, worth up to $999,999,999 and running through November 2026. The contract covers the delivery of CIMZIA 200 MG VIAL KITS, a specialty pharmaceutical product,...
This federal contract award, valued at $7,419.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which does not have a set-aside designation, is a delivery order contract for the procurement of CIMZIA 2X200 MG/ML syringe kits. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $11,971.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of CIMZIA 2X200 MG/ML Syringe Kits, with a performance period ending on November 14, 2024. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,473.73, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of $999,999,999 and runs through November 2026. The contract is for the supply of CIMZIA 2X200 MG/ML syringe kits, a specialty pharmaceutical product. As an...
This federal contract award, valued at $43,402.10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cimzia 2x200 mg/ml syringe kits. The $67,188.14 firm fixed-price contract has an ultimate completion date of August 31, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,280.28 firm fixed-price delivery order is for CIMZIA 2X200 MG/ML syringe kits, with a period of performance through August 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $7,149.98, is for the supply of CIMZIA 2X200 MG/ML SYRINGE KITS, a specialty pharmaceutical product. This IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT2FS
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,530.53, is a delivery order with a firm fixed price. The contract is not designated as a set-aside and covers the procurement of Cimzia 2x200 mg/ml syringe kits. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award demonstrates Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 5/27/25, 9:45 AM